Xoma | XOMA - Capital Social Ordinario

Precio De Mercado
36.74
Cambio Diario
-0.02 -0.05%
Mensual
36.28%
Anual
83.98%
Q2 Expectativa
35.74




Capital Social Ordinario Cambio Fecha
AbbVie USD 1.77B 1.75B 2025-06
Agenus USD 35.32M 2.51M 2025-12
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Ardelyx USD 244.35M 1.38M 2025-12
aTyr Pharma USD 16.65M 81.34M 2025-12
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Celldex Therapeutics USD 66.55M 102K 2025-12
Curis USD 12.93M 12.87M 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Emergent BioSolutions USD 100K 0 2023-06
Incyte USD 198.46M 2.33M 2025-12
MacroGenics USD 63.32M 60K 2025-12
Novartis USD 1.91B 10.64M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Prothena USD 53.83M 3K 2025-12
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Xoma USD 87K 1000 2024-06